Thomas Reiser/LinkedIn
Nov 20, 2025, 13:42
Rebalancing Therapies Poised to Transform Hemophilia Care․ Explore the New ISTH CME
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared on X:
” New ISTH CME activity available:
Rebalancing Therapies for Hemophilia Are You Ready?
Gain the latest insights on emerg. rebalancing treatments, compare evolving clin. profiles & learn how to prepare your team for what’s next in hemophilia care.”
Read more here.
Stay updated with Hemostasis Today.
-
Jul 10, 2026, 14:29Beril Awuor: The Functional Architecture of Blood and Its Physiological Significance
-
Jul 10, 2026, 14:15Arezoo Esteki: The Rising Role of Platelet-Rich Plasma in Precision Regenerative Care
-
Jul 10, 2026, 14:04Morgan Fogarty: A New Era of Continuous Bedside Brain Monitoring After Stroke
-
Jul 10, 2026, 13:50Nikki Veale: The Digital Stroke Recovery Programme in Cornwall Is Out Now
-
Jul 10, 2026, 13:43Fiona Bardon: Shaping Better Long-Term Stroke Care Through the CLASP Pathway
-
Jul 10, 2026, 13:22Rohan Arora: Can Artificial Intelligence Improve Informed Consent in Stroke Clinical Trials?
-
Jul 10, 2026, 12:47Mavis Agnes Kisakye: Community Education Is Transforming Hemophilia Awareness in Uganda
-
Jul 10, 2026, 12:36Pouya Tahsili-Fahadan: New Machine Learning Model Enhances Risk Prediction in Acute Ischemic Stroke
-
Jul 10, 2026, 10:58Yara Alyahyawi: Advancing Epigenetic Therapy for Hemophilia B